Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anika Therapeutics, Inc.
Pharmaceutical company adds new business development executive
November 6th, 2004
Anika Therapeutics, Inc., (ANIK) announced the appointment of Elizabeth C. Chen as senior vice president of marketing and business development, a newly created executive position. Chen will be responsible for developing and implementing strategic and tactical initiatives worldwide to drive Anika's corporate growth. Most recently, she was general manager of an ICN Pharmaceuticals, Inc., subsidiary, Circe Biomedical Company, where she also served as chief operating officer from 2000 to 2003. Earlier, Chen was president and chief executive officer of Marathon Biopharmaceuticals, LLC, which was spun out of Seragen and later acquired by Ligand Pharmaceuticals, Inc., in...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
